Patent fight over knitted trainers could set trend in sportswear

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Patent fight over knitted trainers could set trend in sportswear

Yesterday an injunction against adidas over trainers that use a knitted upper was lifted in Germany. The dispute, brought by Nike, could start a series of patent cases in the sportswear industry

The Nike European patent concerns a shoe with a meltable polymer material used in its knitted upper. The technology is used in the Nike Flyknit shoe, melting the knitted yarn together to add reinforcement to the knitted construction, which makes it seamless and very light.

Adidas adizero primeknit upper

The adiZero Primeknit shoe, which was the subject of the suit, was launched later but had been in production for three years, according to adidas. Pictured is the one-piece upper of the shoe.

The Nuremberg district court lifted an ex parte injunction won by Nike on September 24. Adidas had succeeded in stopping the enforcement of the injunction on October 10.

The case is unusual because sportswear companies are rarely involved in patent suits, despite often owning hundreds of patents over their products.

"That is changing now, as the market becomes more driven by technologies such as this, rather than straight design," comments a lawyer close to the case. "Sportswear increasingly uses advanced materials, chemical compounds and technology built into the products."

It is likened to the automobile industry in Germany, which is rarely the subject of patent cases. Most disputes are settled, end in cross-licensing or "the infringement is merely tolerated",says the lawyer.

Bardehle Pagenberg is representing adidas in the case and Wragge & Co and Prinz & Partner are representing Nike.

more from across site and SHARED ros bottom lb

More from across our site

Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Abion says integration with Baylos marks an important step in the company’s international expansion plans
Via Licensing Alliance continues its China push as another smartphone manufacturer joins patent pool as licensee
Law firm mergers have the potential to reshape IP teams, and partners who were at the coalface of previous tie-ups say early coordination and flexibility can make the difference
Women are entering the IP profession, but still too few are being trusted with the clients, cases, and credit that may open the path to leadership
In other news, Australia’s IP office has announced expanded search options, and an EPO report shed light on slow progress relating to women inventors in Europe
Managing IP speaks with up-and-coming women lawyers at five law firms about fighting imposter syndrome, maintaining work-life balance and why real representation matters
Gift this article